Ask a pathologist by Scheitler, Kristen & Coberly, Emily
Ask a Pathologist 
 
Kristen Scheitler
1
, Emily Coberly
1
 
 
1
Department of Pathology and Anatomical Sciences, University of Missouri Health Care, Columbia, MO 
 
Correspondence: Emily Coberly (coberlye@health.missouri.edu) 
 
Received March 15, 2017; accepted March 22, 2017 
 
 
Question:  
My patient had a normal platelet count on admission but became acutely thrombocytopenic several days later.  
How do I distinguish heparin-induced thrombocytopenia (HIT) from drug-induced thrombocytopenia caused by 
other medications? 
 
Answer:  
Several different drugs may cause thrombocytopenia. Heparin-induced thrombocytopenia (HIT), most often 
associated with unfractionated heparin, occurs when the antigen-binding fragment (Fab) of pathogenic IgG 
binds to a complex of heparin and platelet factor 4 (PF4).  The crystallizable region (Fc) of the antibody then 
binds to platelet FcyIIa receptors, resulting in platelet activation and a hypercoagulable state. The 
thrombocytopenia in HIT is usually mild to moderate in severity, with a mean platelet nadir of around 60 x 
10
9
/L. Due to the risk of thrombosis, platelet transfusion should be avoided. 
   Other drugs may also induce immunologic thrombocytopenia. Besides heparin, the two drugs most commonly 
implicated are quinine (in the outpatient setting) and vancomycin (in the inpatient setting). For both of these 
drugs, the Fab portion of the antibody binds to platelet surface glycoproteins, while the Fc portion binds to 
receptors on phagocytic cells.  This results in accelerated platelet clearance by the reticuloendothelial system 
and a severe thrombocytopenia, usually with a platelet nadir of less than 20 x 10
9
/L or a drop in platelets 
beyond 50% of original platelet count.  Drug-induced thrombocytopenia from these medications is associated 
with an increased risk of bleeding, and patients may be refractory to platelet transfusion as the transfused 
platelets are also quickly destroyed by antibodies. 
   In severely ill hospitalized patients, heparin and vancomycin may be simultaneously administered, making it 
difficult to determine if the thrombocytopenia is caused by underlying disease or by one of the medications.  A 
sudden severe thrombocytopenia, particularly if the platelet count falls below 20 x 10
9
/L, should raise suspicion 
that a non-heparin drug such as vancomycin may be responsible. Vancomycin-induced thrombocytopenia 
should be suspected in patients who have initiated treatment within the past 6-8 days. If drug-induced 
thrombocytopenia from vancomycin or another drug is suspected, the drug should be discontinued immediately.  
The platelet count will usually return to baseline within a few days of stopping the drug.  
   If you suspect drug-induced thrombocytopenia from a non-heparin medication, contact your pathologist, who 
can assist with ordering the appropriate reference lab testing to confirm the diagnosis.  
   References for evaluating a patient with possible drug-induced thrombocytopenia can be accessed using 
http://www.ouhsc.edu/platelets/ditp.html, which is maintained by the University of Oklahoma and provides a 
comprehensive survey of drugs that have been reported to cause drug-induced thrombocytopenia. 
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